These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens]. Manfredi R Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159 [TBL] [Abstract][Full Text] [Related]
14. Tigecycline: first of a new class of antimicrobial agents. Rose WE; Rybak MJ Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487 [TBL] [Abstract][Full Text] [Related]
15. [Tigecycline: a new antibiotic in ongoing clinical development]. Stahl JP Med Mal Infect; 2005 Feb; 35(2):62-7. PubMed ID: 15780894 [TBL] [Abstract][Full Text] [Related]
16. [New antimicrobials against Gram-positive organisms]. Montejo M Nefrologia; 2008; 28 Suppl 6():119-24. PubMed ID: 18957022 [TBL] [Abstract][Full Text] [Related]
17. New antibiotic agents: problems and prospects. Weber DJ; Rutala WA Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500 [TBL] [Abstract][Full Text] [Related]
18. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus. Scheinfeld N J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167 [TBL] [Abstract][Full Text] [Related]
19. Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections. Arias CA; Mendes RE; Stilwell MG; Jones RN; Murray BE Clin Infect Dis; 2012 Apr; 54 Suppl 3(Suppl 3):S233-8. PubMed ID: 22431854 [TBL] [Abstract][Full Text] [Related]